• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
You are here:   Home > EZSourcing > Sourcing Request > Semaglutide

Semaglutide
Categories: API Equipment>Chemical and Biochemical Reactors
Expected Quantity: 100 Gram(s)
Valid To: 2027-06-03
Delivery To: China Mainland
Date Posted: 2025-03-04
The sourcing request is closed now.
Request Details
Semaglutide, sold under the brand names Ozempic, Wegovy, and Rybelsus, is an antidiabetic drug for type 2 diabetes and a weight loss drug for long-term weight management developed by Novo Nordisk in 2012. It is a peptide similar to glucagon-like peptide-1 with a modified side chain. It can be injected subcutaneously or orally. NovoTex is used to treat type 2 diabetes, while NovoWin is used for weight loss.
Buyer‘s Business Info
Only registered supplier members are allowed to view Buyers contact details
Please
Quote
Recommended Sourcing Requests
Pharmaceutical and Medicine products
Quantity：100 Box(es)
Date Posted：2025-02-24
More >
VIGABATRIN
Quantity：5 Ton(s)
Date Posted：2025-02-17
More >
Fucus p.e.
Quantity：500 Kilogram(s)
Date Posted：2025-02-07
More >
Ceftriaxone inj 1g
Quantity：1.5 million pieces per year Piece(s)
Date Posted：2025-02-02
More >

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service